These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3961)

  • 1. Effects of cedilanid-D in combination with metoprolol on exercise tolerance and systolic time intervals in angina pectoris.
    Ekelund LG; Johnsson G; Melcher A; Oro L
    Am J Cardiol; 1976 Mar; 37(4):630-4. PubMed ID: 3961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
    Borer JS; Comerford MB; Sowton E
    J Int Med Res; 1976; 4(1):15-22. PubMed ID: 799974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests.
    Ekelund LG; Olsson AG; Orö L; Rössner S
    Br Heart J; 1976 Feb; 38(2):155-61. PubMed ID: 4080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cedilanid-D and alprenolol in angina pectoris.
    Ekelund LG; Johnsson G; Melcher A; Orö L
    Eur J Clin Pharmacol; 1973 Aug; 6(2):113-8. PubMed ID: 4769694
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of metoprolol in angina pectoris. A subacute study with exercise tests and a long-term tolerability study.
    Keyriläinen O; Uusitalo A
    Acta Med Scand; 1976; 199(6):491-7. PubMed ID: 7100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O; Uustialo A
    Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
    Araki H; Hayata N; Nakamura M
    Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
    Keyriläinen O; Uusitalo A
    Ann Clin Res; 1978 Aug; 10(4):185-90. PubMed ID: 30388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta blockade with betaxolol on left ventricular systolic function in chronic stable angina pectoris and left ventricular dysfunction.
    Alpert MA; Singh A; Holmes RA; Sanfelippo JF; Flaker GC; Villarreal D; Mukerji V; Morgan RJ
    Am J Cardiol; 1986 Apr; 57(10):721-4. PubMed ID: 2870631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    Am J Med; 1980 Feb; 68(2):243-50. PubMed ID: 6101934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of metoprolol on the exercise tolerance in patients with stable angina pectoris (author's transl)].
    Tomei G; Mosti G; Veltri M; Giusti C
    G Ital Cardiol; 1978; 8(12):1286-92. PubMed ID: 367865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic time intervals as possible predictors of pressure response to sustained beta-adrenergic blockade in arterial hypertension. A within-patient, placebo-controlled study.
    Verdecchia P; Brignole M; Delfino G; Queirolo C; De Marchi G; Bertulla A
    Hypertension; 1983; 5(1):140-6. PubMed ID: 6336719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy.
    Currie PJ; Kelly MJ; McKenzie A; Harper RW; Lim YL; Federman J; Anderson ST; Pitt A
    J Am Coll Cardiol; 1984 Jan; 3(1):203-9. PubMed ID: 6140277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of digitalis on cardiac function before and after autonomic blockade.
    Cokkinos DV; Demopoulos JN; Heimonas ET; Vorides EM
    Acta Cardiol; 1978; 33(3):185-94. PubMed ID: 360742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris.
    Frick MH; Luurila O
    Ann Clin Res; 1976 Dec; 8(6):385-92. PubMed ID: 795362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of practolol on exercise tolerance and cardiac haemodynamics and metabolism in patients with coronary artery disease.
    Dagenais GR; Moisan A; Marquis Y; Davies RO; Blouin S
    Cardiovasc Res; 1976 Jan; 10(1):25-36. PubMed ID: 1253193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment.
    Bengtsson C; Johnsson G; Regårdh CG
    Clin Pharmacol Ther; 1975 Apr; 17(4):400-8. PubMed ID: 235398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological effects of concomitant administration of beta-adrenoceptor blocker and agonist in normal subjects: characterization by heart rate response to exercise. Effects of beta-blocker combined with beta-agonist.
    Karita M; Sato H; Koretsune Y; Imai K; Ozaki H; Yokoyama H; Hori M; Takeda H; Inoue M; Kamada T
    Eur J Clin Pharmacol; 1995; 48(6):467-71. PubMed ID: 8582465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.